Midomafetamine Recruiting Phase 1 Trials for Post Traumatic Stress Disorder (PTSD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03752918The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.